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Abstract
Clinical decision support (CDS) embedded within the electronic health record (EHR) is a potential 
antibiotic stewardship strategy for hospitalized patients. Reduction in urine testing and treating 
asymptomatic bacteriuria (ASB) is an important strategy to promote antibiotic stewardship. We 
created an intervention focused on reducing urine testing for asymptomatic patients at a large 
tertiary care center. The objective of this study was to design an intervention to reduce unnecessary 
urinalysis and urine culture (UC) orders as well as the treatment of ASB. We performed a 
quasiexperimental study among adult inpatients at a single academic institution. We implemented 
a bundled intervention, including information broadcast in newsletters, hospital-wide screensavers, 
and passive CDS messages in the EHR. We investigated the impact of this strategy on urinalysis, 
UC orders, and on the treatment of ASB by using an interrupted time series analysis. Our 
intervention led to reduced UC order as well as reduced antibiotic orders in response to urinalysis 
orders and UC results. This easily implementable bundle may play an important role as an 
antibiotic stewardship strategy.
INTRODUCTION
Reducing the treatment of asymptomatic bacteriuria (ASB), or isolation of bacteria from a 
urine specimen in a patient without urinary tract infection (UTI) symptoms, is a key goal of 
antibiotic stewardship programs.1 Treatment of ASB has been associated with the emergence 
of resistant organisms and subsequent UTI risk among women with recurrent UTI.2,3 The 
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Infectious Diseases Society of America and the American Board of Internal Medicine 
Foundation’s Choosing Wisely campaign recommend against treating ASB, with the 
exception of pregnant patients and urogenital surgical patients.1,4
Obtaining urinalyses and urine cultures (UC) in asymptomatic patients may contribute to the 
unnecessary treatment of ASB. In a study of hospitalized patients, 62% received urinalysis 
testing, even though 82% of these patients did not have UTI symptoms.5 Of the patients 
found to have ASB, 30% were given antibiotics.5 Therefore, interventions aimed at reducing 
urine testing may reduce ASB treatment.
Electronic passive clinical decision support (CDS) alerts and electronic education may be 
effective interventions to reduce urine testing.6 While CDS tools are recommended in 
antibiotic stewardship guidelines,7 they have led to only modest improvements in 
appropriate antibiotic prescribing and are typically bundled with time-intensive educational 
interventions.8 Furthermore, most in-hospital interventions to decrease ASB treatment have 
focused on intensive care units (ICUs).9 We hypothesized that CDS and electronic education 
would decrease (1) urinalysis and UC ordering and (2) antibiotic orders for urinalyses and 
UCs in hospitalized adult patients.
METHODS
Population
We conducted a prospective time series analysis (preintervention: September 2014 to June 
2015; postintervention: September 2015 to June 2016) at a large tertiary medical center. All 
hospitalized patients ≥18 years old were eligible except those admitted to services requiring 
specialized ASB management (eg, leukemia and lymphoma, solid organ transplant, and 
obstetrics).1 The study was declared quality improvement by the Johns Hopkins Institutional 
Review Board.
Intervention
In August 2015, we implemented a multifaceted intervention that included provider 
education and passive electronic CDS (supplementary Appendix 1 and supplementary 
Appendix 2). Materials were disseminated through hospital-wide computer workstation 
screensavers and a 1-page e-mailed newsletter to department of medicine clinicians. The 
CDS tool included simple informational messages recommending against urine testing 
without symptoms and against treating ASB; these messages accompanied electronic health 
record (EHR; Allscripts Sunrise Clinical Manager, Chicago, IL) orders for urinalysis, UC, 
and antibiotics commonly used within our institution to treat UTI (cefazolin, cephalexin, 
ceftriaxone, trimethoprim-sulfamethoxazole, nitrofurantoin, and ciprofloxacin). The 
information was displayed automatically when orders for these tests and antibiotics were 
selected; provider acknowledgment was not required to proceed.
Data Collection
The services within our hospital are geographically located. We collected orders for 
urinalysis, UC, and the associated antibiotics for all units except those housing patients 
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excluded from our study. As the CDS tool appeared only in the inpatient EHR, only 
postadmission orders were included, excluding emergency department orders. For 
admissions with multiple urinalyses, urinalysis orders placed ≥72 hours apart were eligible. 
Only antibiotics ordered for ≥24 hours were included, excluding on-call and 1-time 
antibiotic orders.
Our approach to data collection attempted to model a clinician’s decision-making pathway 
from (1) ordering a urinalysis, to (2) ordering a UC in response to a urinalysis result, to (3) 
ordering antibiotics in response to a urinalysis or UC result. We focused on order placement 
rather than results to prioritize avoiding testing in asymptomatic patients, as our institution 
does not require positive urinalyses for UC testing (reflex testing). Urinalyses resulted 
within 1 to 2 hours, allowing for clinicians to quickly order UCs after urinalysis result 
review. Urinalysis and UC orders per monthly admissions were defined as (1) urinalyses, (2) 
UCs, (3) simultaneous urinalysis and UC (within 1 hour of each other), and (4) UCs ordered 
1 to 24 hours after urinalysis. We also analyzed the following antibiotic orders per monthly 
admissions: (1) simultaneous urinalysis and antibiotic orders, (2) antibiotics ordered 1 to 24 
hours after urinalysis order, and (3) antibiotics ordered within 24 hours of the UC result.
Outcome Measures
All outcome measures were calculated as the change over time per total monthly admissions 
in the preintervention and postintervention periods. In addition to symptoms, urinalysis is a 
critical, measurable early step in determining the presence of ASB. Therefore, the primary 
outcome measure was the postintervention change in monthly urinalysis orders, and the 
secondary outcome measure was the postintervention change in monthly UC orders. 
Additional outcome measures included monthly postintervention changes in (1) UC ordered 
1 to 24 hours after urinalyses, (2) urinalyses and antibiotics ordered simultaneously, (3) 
antibiotic orders within 1 to 24 hours of urinalyses, and (4) antibiotics ordered within 24 
hours of UC result.
Statistical Analysis
Statistical analyses were performed by using Stata (version 14.2; StataCorp LLC, College 
Station, TX). An interrupted time series analysis was performed to compare the change in 
orders per 100 monthly admissions in preintervention and postintervention periods. To do 
this, we created 2 separate segmented linear regression models for each dependent variable, 
pre- and postintervention. Normality was assumed because of large numbers. Rate 
differences per 100 monthly admissions are also calculated as the total number of orders 
divided by the total number of admissions in postintervention and preintervention periods 
with Mantel-Haenszel estimators. Differences were considered statistically significant at P 
≤ .05.
RESULTS
After the intervention, urinalysis orders did not decrease (−10.2%; P = .24), but UC orders 
decreased 6.3% (P < .001; Figure.; Table). There were fewer simultaneous urinalysis and 
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UC orders after the intervention (−5.8%; P < .001). A decrease in UC following urinalyses 
within 1 to 24 hours did not reach statistical significance (−0.66%; P = .33).
There was a decrease in urinalysis orders followed by antibiotic orders within 1 to 24 hours 
(−0.56%; P = .021) and in UC results followed by an antibiotic order within 24 hours 
(−0.24%; P = .036). However, a decrease in urinalyses and antibiotics ordered 
simultaneously did not reach statistical significance (−0.24%; P = .073).
DISCUSSION
A multifaceted but simple bundle of CDS and provider education reduced UC testing but not 
urinalyses in a large tertiary care hospital. The bundle also reduced antibiotic ordering in 
response to urinalyses as well as antibiotic ordering in response to UC results.
Other in-hospital CDS tools to decrease ASB treatment have focused only on ICUs.9,10 Our 
intervention was evaluated hospital-wide and included urinalyses and UCs. Our intervention 
was clinician directed and not laboratory directed, such as a positive urinalysis reflexing to a 
UC. Simultaneous urinalysis and UC testing may lead to ASB treatment, as clinicians treat 
the positive UC and ignore the negative urinalysis.11,12 Therefore, we focused on UCs being 
sent in response to urinalyses.
We chose to focus on laboratory testing data instead of administrative diagnoses for UTI. 
The sensitivity of administrative data to determine similar conditions such as catheter-
associated UTIs is low (0%).13
Our single-center study may not be generalizable to other settings. We did not include 
emergency department patients, as this location used a different EHR. In addition, given the 
600,000 yearly hospital admissions, it was impractical to assess the appropriateness of each 
antibiotic-based documentation of symptoms. Instead of focusing on symptoms of ASB or 
UTI diagnoses, we focused on ordering urinalysis, UC, and antibiotics. In investigating the 
antibiotics most frequently used to treat UTI in our hospital, we may have both missed some 
patients who were treated with other antibiotics for ASB (eg, 4th generation cephalosporins, 
penicillins, carbapenems, etc) and captured patients receiving antibiotics for indications 
other than UTI (eg, pneumonia). In our focus on overall ordering practices across a hospital, 
we did not capture data on bladder catheterization status or the predominant organism seen 
in UC. At the time of the intervention, the laboratory did not have the resources for 
urinalysis testing reflexing to UC. However, our intervention did not prevent ordering 
simultaneous urinalysis and UC in symptomatic patients in general or urosepsis in particular. 
With only 12 total time points, the interrupted time series analysis may have been 
underpowered.14 We also do not know if the intervention’s effect would decay over time.
Although the intervention took very little staff time and resources, alert fatigue was a risk.15 
We attempted to mitigate this alert fatigue by making the CDS passive (in the form of a brief 
informational message) with no provider action required. In conversations with providers in 
our institution, there has been dissatisfaction with alerts requiring action, as these are 
thought to be overly intrusive. We are also not clear on which element of the intervention 
bundle (ie, the CDS or the educational intervention) may have had more of an impact, as the 
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elements of the intervention bundle were rolled out simultaneously. It is possible and even 
probable that both elements are needed to raise awareness of the problem. Also, as our EHR 
required all interventions to be rolled out hospital-wide simultaneously, we were unable to 
randomize certain floors or providers to the CDS portion of the intervention bundle. Other 
analyses including the type of hospital unit were beyond the scope of this brief report.
Our intervention bundle was associated with reduced UC orders and reduced antibiotics 
ordered after urinalyses. If a provider does not know there is bacteriuria, then the provider 
will not be tempted to order antibiotics. This easily implementable bundle may play an 
important role as an antimicrobial stewardship strategy for ASB.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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FIG. 
Proportion of admissions with urinalysis and urine culture orders, preintervention (9/2014–
6/2015) and postintervention (9/2015–6/2016).
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